ReviewMikrochimica acta2025
Lab-on-paper diagnostics for blood sample analysis: a review.
Review in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Paper-Based Biosensors for Monitoring Binding, Blocking, and Surrogate Neutralizing Antibody Responses Against Viral Infections.Biosensors · 2026Review
- Cationic covalent organic frameworks for simultaneous capture and high-performance enrichment of multiple angiotensins and aldosterone in human plasma.Mikrochimica acta · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review presents a comprehensive overview of the emerging field of lab-on-paper diagnostics, with a specific focus on blood analysis, underscoring their significance as low-cost, portable, and effective solutions for point-of-care testing in resource-constrained environments. It highlights the novel integration of microfluidic principles on paper substrates, enabling decentralized testing and minimizing reliance on centralized laboratory infrastructure. The review outlines recent technological advancements in device fabrication-such as wax printing, laser cutting, and 2D/3D structural designs-as well as innovative fluid control mechanisms and detection strategies including colorimetry, electrochemical sensing, and fluorescence. A key emphasis is placed on the incorporation of complex, on-chip sample pretreatment processes like plasma separation and analyte concentration, which represent a significant step forward in making lab-on-paper devices suitable for real-world blood diagnostics. Additionally, the work explores the capability of these platforms to detect a wide range of blood-borne biomarkers, highlighting their potential to bridge healthcare gaps globally. While acknowledging current challenges-such as material durability, environmental resilience, and digital integration-this review identifies critical future directions that could drive the widespread adoption and impact of lab-on-paper systems. The work showcases the transformative potential and growing relevance of paper-based diagnostics in achieving equitable and accessible healthcare.
Indexed as
Identifiers
40601027What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.